Brief: Zentalis Strengthens Commercial Leadership With Appointments Of Shannon Campbell To Board Of Directors And Sarah Kelly As SVP Of Commercial Strategy
27/05/2026 21:16
BRIEF-Zentalis Strengthens Commercial Leadership With Appointments Of Shannon Campbell To Board Of Directors And Sarah Kelly As SVP Of Commercial Strategy May 27 (Reuters) - Zentalis Pharmaceuticals Inc ZNTL.O:
ZENTALIS STRENGTHENS COMMERCIAL LEADERSHIP WITH APPOINTMENTS OF SHANNON CAMPBELL TO BOARD OF DIRECTORS AND SARAH KELLY AS SVP OF COMMERCIAL STRATEGY
Source text: ID:nGNXb0SfRr
Further company coverage: ZNTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer